Chronic Obstructive Pulmonary Disease (COPD)

COPD is a progressive respiratory disease characterized by airflow limitation that is not fully reversible. Emphysema destroys alveoli, while chronic bronchitis thickens airways and increases mucus production. Together they cause shortness of breath, coughing, and frequent exacerbations. With early detection and targeted therapy, patients can maintain mobility and quality of life.

Causes & Risk Factors

• Long-term cigarette smoking (including secondhand exposure)
• Occupational dust, chemical fumes, or biomass fuel smoke
• Severe childhood respiratory infections
• Genetic factors such as alpha-1 antitrypsin deficiency
• Asthma-COPD overlap
• Aging and comorbid cardiovascular disease

Symptoms

• Chronic cough with sputum production
• Progressive dyspnea, especially on exertion
• Wheezing or chest tightness
• Frequent respiratory infections
• Fatigue, unintentional weight loss (advanced disease)
• Swelling in ankles or legs if cor pulmonale develops

Seek urgent care for severe shortness of breath, confusion, cyanosis, or signs of infection (fever, purulent sputum).

Diagnosis & Staging

• Spirometry: FEV1/FVC ratio < 0.70 confirms airflow limitation; FEV1 % predicted determines GOLD stage (1–4).
• Symptom burden: mMRC dyspnea scale, COPD Assessment Test (CAT).
• Imaging: chest X-ray or CT scan to assess emphysema, bullae.
• Arterial blood gases for chronic CO2 retention.
• Alpha-1 antitrypsin testing in early-onset or non-smokers.

Treatment & Management

Lifestyle & Self-Care

• Smoking cessation is the most impactful intervention.
• Avoid lung irritants and get vaccinated (influenza, pneumococcal, COVID-19, RSV if eligible).
• Stay physically active; prioritize sleep and nutrition.

Pharmacologic Therapy

• Bronchodilators: Short-acting (SABA/SAMA) for relief; long-acting (LABA/LAMA) for maintenance.
• Inhaled corticosteroids (ICS) in frequent exacerbators or elevated eosinophils.
• Triple therapy (LABA/LAMA/ICS) for severe symptoms.
• Phosphodiesterase-4 inhibitor (roflumilast) or chronic macrolides for select patients.
• Oxygen therapy if resting hypoxemia (PaO2 ≤ 55 mmHg or SpO2 ≤ 88%).
• Pulmonary rehab: structured exercise + education improves dyspnea and quality of life.

Exacerbation Management

• Short course of oral steroids + antibiotics when indicated.
• Update action plan to recognize early flare signs.

Living with COPD

• Practice breathing techniques (pursed-lip, diaphragmatic).
• Break tasks into manageable steps with rest periods.
• Use energy-conservation strategies in daily activities.
• Monitor weight and appetite; consider high-calorie supplements.
• Address anxiety or depression with counseling or support groups.

Complications

• Frequent respiratory infections and hospitalizations
• Pulmonary hypertension and right-sided heart failure
• Osteoporosis, muscle wasting
• Reduced cognitive function due to chronic hypoxemia

Research & Future Directions

Advances focus on biologics for eosinophilic COPD, precision inhaler therapy via digital biomarkers, and regenerative strategies to repair alveolar damage.

Experimental & Emerging Treatments

• Endobronchial Valve & Coil Therapy: Minimally invasive procedures collapse diseased lung segments, improving elastic recoil for emphysema patients not eligible for surgery.
• Cell-Based Regeneration: Trials infusing mesenchymal stem cells or secretome therapies aim to reduce inflammation and rebuild alveolar structures.
• Alpha-1 Antitrypsin Gene Therapy: Investigational vectors deliver functional AAT genes, offering durable protection for deficiency-related COPD.
• Digital Phenotyping & Closed-Loop Inhalers: Smart inhalers paired with AI adjust dosing or prompt early interventions based on real-time physiology.

Track COPD with Diagnoza.care

Breathe Easier with Diagnoza.care – Log symptoms, peak flows, inhaler usage, exacerbations, and oxygen saturations, schedule pulmonology visits and pulmonary rehab sessions, capture medication side effects, and let the AI companion flag trends before flare-ups hit.

---

Medical Disclaimer: Informational only. Work with your pulmonologist for individualized diagnostics, inhaler regimens, and oxygen or procedure decisions. Sources: Global Initiative for Chronic Obstructive Lung Disease (GOLD), American Thoracic Society, National Heart, Lung, and Blood Institute